P Saiag Selected Research

P Saiag Research Topics

Disease

11	Melanoma (Melanoma, Malignant) 03/2022 - 08/2005
4	Neoplasm Metastasis (Metastasis) 09/2021 - 02/2014
3	Neoplasms (Cancer) 09/2021 - 02/2004
3	Skin Neoplasms (Skin Cancer) 10/2020 - 08/2005
3	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2017 - 09/2009
3	Margins of Excision 08/2011 - 02/2004
3	Infections 08/2008 - 12/2001
2	Carcinoma (Carcinomatosis) 10/2022 - 08/2000
2	Dermatofibrosarcoma 08/2011 - 02/2004
2	Acquired Immunodeficiency Syndrome (AIDS) 12/2001 - 05/2000
1	Dropped Head Syndrome 01/2018
1	Mycosis Fungoides 10/2015
1	Burns 12/2010
1	Balanitis 12/2010
1	Vulvitis 12/2010
1	Purpura 12/2010
1	Insect Bites and Stings (Insect Bite) 12/2010
1	Urticaria (Hives) 12/2010
1	Atopic Dermatitis (Atopic Eczema) 12/2010
1	Condylomata Acuminata (Genital Wart) 10/2009
1	Warts (Wart) 10/2009
1	Exfoliative Dermatitis (Erythroderma) 08/2008
1	Cardiac Arrhythmias (Arrythmia) 04/2008
1	Acute Generalized Exanthematous Pustulosis 04/2008
1	Exanthema (Rash) 04/2008
1	Linear IgA Bullous Dermatosis 03/2008
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 10/2006
1	Herpes Genitalis (Genital Herpes) 10/2006
1	Erythema Multiforme 10/2006
1	Genetic Predisposition to Disease (Genetic Predisposition) 08/2006
1	Basal Cell Nevus Syndrome (Gorlin Syndrome) 08/2006
1	Piebaldism (Partial Albinism) 08/2005
1	Inborn Genetic Diseases (Disease, Hereditary) 08/2005
1	Oculocutaneous albinism type 2 08/2005
1	Blister (Bulla) 04/2004
1	Pruritus (Itching) 04/2004
1	Bullous Pemphigoid (Pemphigoid) 04/2004
1	Benign Fibrous Histiocytoma (Dermatofibroma) 02/2004
1	Residual Neoplasm 02/2004
1	Basal Cell Carcinoma (Rodent Ulcer) 02/2004
1	Wounds and Injuries (Trauma) 02/2004
1	Body Weight (Weight, Body) 01/2003
1	Pemphigus (Pemphigus Vulgaris) 01/2003
1	Compartment Syndromes 11/2002
1	Cellulitis 11/2002

Drug/Important Bio-Agent (IBA)

3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2021 - 01/2018
2	Formaldehyde (Formol)FDA Link 10/2022 - 02/2004
2	dabrafenibIBA 03/2022 - 09/2021
2	trametinibIBA 03/2022 - 09/2021
2	VemurafenibIBA 02/2016 - 07/2015
2	Imiquimod (Aldara)FDA LinkGeneric 02/2014 - 10/2009
2	RNA (Ribonucleic Acid)IBA 10/2009 - 05/2000
2	Biological ProductsIBA 09/2009 - 04/2004
2	NucleosidesIBA 05/2000 - 03/2000
1	NivolumabIBA 09/2021
1	pembrolizumabIBA 09/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	secukinumabIBA 12/2017
1	apremilastIBA 12/2017
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2015
1	Polyvinyl Chloride (PVC)IBA 07/2015
1	Pharmaceutical PreparationsIBA 12/2010
1	DNA (Deoxyribonucleic Acid)IBA 10/2009
1	Trichloroacetic AcidIBA 10/2009
1	Podophyllotoxin (Condylox)FDA LinkGeneric 10/2009
1	BCG Vaccine FDA Link 08/2008
1	Escitalopram FDA Link 08/2008
1	fluindioneIBA 04/2008
1	Tacrolimus (Prograf)FDA LinkGeneric 03/2008
1	Ointments (Pastes)IBA 03/2008
1	Antiviral Agents (Antivirals)IBA 10/2006
1	Complement System Proteins (Complement)IBA 08/2006
1	Type 1 Melanocortin ReceptorIBA 08/2005
1	Proteins (Proteins, Gene)FDA Link 08/2005
1	AntigensIBA 04/2004
1	AntibodiesIBA 04/2004
1	ParaffinIBA 02/2004
1	Prednisone (Sone)FDA LinkGeneric 01/2003
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2003
1	Azathioprine (Imuran)FDA LinkGeneric 01/2003

Therapy/Procedure

10	Therapeutics 09/2021 - 03/2000
4	Mohs Surgery (Mohs' Micrographic Surgery) 10/2022 - 02/2004
2	Immunotherapy 03/2019 - 12/2018
2	Radiotherapy 05/2016 - 06/2011
2	Highly Active Antiretroviral Therapy (HAART) 10/2009 - 05/2000
1	Investigational Therapies (Experimental Therapy) 10/2020
1	Secondary Prevention 10/2020
1	Length of Stay 08/2016
1	Medical Day Care (Partial Hospitalization) 08/2016
1	Injections 05/2016
1	Palliative Care (Palliative Therapy) 02/2014
1	Electrocoagulation (Electrocautery) 02/2014
1	Gas Lasers 02/2014
1	Drug Therapy (Chemotherapy) 06/2011
1	Phototherapy (Light Therapy) 10/2009
1	Aftercare (After-Treatment) 10/2009
1	Biological Therapy 09/2009
1	Sutures (Suture) 02/2004
1	Local Anesthesia 02/2004